发明名称 Estrogen receptor modulators and uses thereof
摘要 A compound that has the structure of Formula (XII): wherein, X 1 is CH, CR 3 or N; X 2 is N, CH, or CR 3 ; Z is -OH or -OR 10 ; R 2 is C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, C 1 -C 4 deuteroalkyl, C 3 -C 6 cycloalkyl, or -C 1 -C 4 alkylene-W; W is hydroxy, halogen, CN, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkoxy, C 1 -C 4 haloalkoxy, and C 3 -C 6 cycloalkyl; each R 3 is independently halogen, C 1 -C 4 alkyl, or C 1 -C 4 fluoroalkyl; each R 4 is independently halogen, -CN, -OR 9 , -S(=O) 2 R 10 , C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, or C 1 -C 4 heteroalkyl; each R 5 is independently halogen, -CN, -OR 9 , -S(=O) 2 R 10 , C 1 -C 4 alkyl, C 1 -C 4 fluoroalkyl, or C 1 -C 4 heteroalkyl; R 6 is H, C 1 -C 4 alkyl, or halogen; R 7 is H, C 1 -C 4 alkyl, or halogen; R 9 is H, C 1 -C 6 alkyl, C 1 -C 6 fluoroalkyl, or C 3 -C 6 cycloalkyl; R 10 is C 1 -C 6 alkyl; m is 0, 1, or 2; n is 0, 1, 2, 3, or 4; and p is 0, 1, or 2; or a pharmaceutically acceptable or N-oxide thereof.
申请公布号 SI2735562(T1) 申请公布日期 2015.07.31
申请号 SI20110030472T 申请日期 2011.09.15
申请人 SERAGON PHARMACEUTICALS, INC. 发明人 SMITH NICHOLAS D.;KAHRAMAN MEHMET;GOVEK STEVEN P.;NAGASAWA JOHNNY Y.;LAI ANDILIY G.;JULIEN JACKALINE D.;HERBERT MARK R.;BONNEFOUS CELINE;DOUGLAS KARENSA L.
分类号 主分类号
代理机构 代理人
主权项
地址